Bank Julius Baer & Co. Ltd Zurich Purchases 244,000 Shares of Kenvue Inc. $KVUE

Bank Julius Baer & Co. Ltd Zurich lifted its holdings in Kenvue Inc. (NYSE:KVUE) by 14,361.4% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 245,699 shares of the company’s stock after buying an additional 244,000 shares during the period. Bank Julius Baer & Co. Ltd Zurich’s holdings in Kenvue were worth $5,249,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of KVUE. Trust Co. of Vermont boosted its position in Kenvue by 266.8% in the second quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock worth $33,000 after purchasing an additional 1,150 shares during the last quarter. Truvestments Capital LLC bought a new stake in shares of Kenvue during the 1st quarter worth $37,000. Clal Insurance Enterprises Holdings Ltd boosted its holdings in shares of Kenvue by 378.5% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,627 shares of the company’s stock worth $39,000 after buying an additional 1,287 shares during the last quarter. First Pacific Financial purchased a new position in shares of Kenvue in the 2nd quarter worth about $54,000. Finally, Ransom Advisory Ltd bought a new position in Kenvue during the first quarter valued at about $56,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have commented on KVUE shares. Citigroup lowered their price objective on shares of Kenvue from $20.00 to $17.00 and set a “neutral” rating on the stock in a research report on Thursday, October 9th. Barclays lifted their price target on shares of Kenvue from $17.00 to $18.00 and gave the stock an “equal weight” rating in a report on Monday, November 10th. Deutsche Bank Aktiengesellschaft set a $18.00 price objective on Kenvue in a research note on Friday, October 24th. Weiss Ratings reissued a “hold (c-)” rating on shares of Kenvue in a research report on Tuesday, October 14th. Finally, Canaccord Genuity Group reaffirmed a “hold” rating and set a $15.00 price target (down previously from $26.00) on shares of Kenvue in a research report on Wednesday, October 29th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, twelve have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Kenvue presently has a consensus rating of “Hold” and an average price target of $20.23.

Kenvue Stock Up 3.0%

Kenvue stock opened at $16.63 on Friday. The firm has a 50 day simple moving average of $16.17 and a 200 day simple moving average of $19.82. The company has a current ratio of 0.98, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 1-year low of $14.02 and a 1-year high of $25.17. The firm has a market capitalization of $31.86 billion, a price-to-earnings ratio of 22.17, a P/E/G ratio of 2.24 and a beta of 0.71.

Kenvue (NYSE:KVUE) last posted its earnings results on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.01. The firm had revenue of $3.76 billion for the quarter, compared to the consensus estimate of $3.83 billion. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.The business’s quarterly revenue was down 3.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.28 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, November 26th. Shareholders of record on Wednesday, November 12th will be issued a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a yield of 5.0%. The ex-dividend date of this dividend is Wednesday, November 12th. Kenvue’s payout ratio is presently 110.67%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.